Andrew Guggenhime, President and CFO at Vaxcyte, Inc. (PCVX), sold 36,000 shares at $28.00 ($1.0M) on 2022-08-25, disclosed to the SEC on 2022-08-29.
Open-market sale of $1.0M PCVX by President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.00 | 17,052 | $477K | 47.4% |
| 2 | $28.00 | 1,295 | $36K | 3.6% |
| 3 | $28.00 | 17,653 | $494K | 49.0% |
| Total | $28.00 avg | 36,000 | $1.0M | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $530K | — | Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |